Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

被引：0

作者：

Gwan Gyu Song

Young Ho Lee

机构：

[1] Korea University College of Medicine,Department of Rheumatology

[2] Korea University Anam Hospital,Division of Rheumatology, Department of Internal Medicine

[3] Korea University College of Medicine,undefined

来源：

Clinical Drug Investigation | 2019年 / 39卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The original version of this article unfortunately contained a mistake. The corresponding author was incorrect.

引用

页码：701 / 701

共 50 条

[1] COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND APREMILAST IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Lee, Young Ho
Song, Gwan Gyu
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1275 - 1276
[2] Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Song, Gwan Gyu
Lee, Young Ho
[J]. CLINICAL DRUG INVESTIGATION, 2019, 39 (05) : 421 - 428
[3] Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Gwan Gyu Song
Young Ho Lee
[J]. Clinical Drug Investigation, 2019, 39 : 421 - 428
[4] Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (vol 39, pg 421, 2019)
Song, Gwan Gyu
Lee, Young Ho
[J]. CLINICAL DRUG INVESTIGATION, 2019, 39 (07) : 701 - 701
[5] Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
Lee, Y. H.
Song, G. G.
[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (06): : 590 - 603
[6] Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Lee, Young Ho
Song, Gwan Gyu
[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (07) : 868 - 875
[7] COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND UPADACITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Lee, Young Ho
Song, Gwan Gyu
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 751 - 751
[8] Comparison of the efficacy and safety of tofacitinib and baricitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
Bae, S-C
Lee, Y. H.
[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (06): : 559 - 567
[9] Comparison of the efficacy and safety of tofacitinib and mavrilimumab in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Sung, Yoon-Kyoung
Lee, Young Ho
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (08) : 557 - 565
[10] Comparison of the efficacy and safety of tofacitinib and upadacitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials
Song, Gwan Gyu
Choi, Sung Jae
Lee, Young Ho
[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (08) : 1563 - 1571

← 1 2 3 4 5 →